Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study.
Budde LE, Assouline S, Sehn LH, Schuster SJ, Yoon SS, Yoon DH, Matasar MJ, Bosch F, Kim WS, Nastoupil LJ, Flinn IW, Shadman M, Diefenbach C, Cheah CY, Ma CY, Huang H, Kwan A, Wei MC, Yin S, Bartlett NL. Budde LE, et al. Among authors: matasar mj. J Clin Oncol. 2024 Jul 1;42(19):2250-2256. doi: 10.1200/JCO.23.02329. Epub 2024 Mar 28. J Clin Oncol. 2024. PMID: 38547425 Free PMC article. Clinical Trial.
Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience.
Pak TK, Dixon BN, Buege MJ, Dao PH, Leary MH, Jarrett JC, Duggan TA, Caron P, Falchi L, Hamlin P, Hamilton A, Matasar MJ, Moskowitz A, Noy A, Owens CN, Von Keudell G, Younes A, Zelenetz AD, Kumar A. Pak TK, et al. Among authors: matasar mj. Leuk Lymphoma. 2022 Apr;63(4):876-884. doi: 10.1080/10428194.2021.2002318. Epub 2021 Nov 16. Leuk Lymphoma. 2022. PMID: 34784853
Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era.
Qualls D, Imber BS, Okwali M, Hamlin PA, Kumar A, Lahoud OB, Matasar MJ, Noy A, Owens C, Zelenetz AD, North VS, Schöder H, Dogan A, Salles G, Yahalom J, Falchi L. Qualls D, et al. Among authors: matasar mj. Br J Haematol. 2023 Feb;200(4):524-527. doi: 10.1111/bjh.18590. Epub 2022 Dec 9. Br J Haematol. 2023. PMID: 36484627 Free PMC article. No abstract available.
Overview of lymphoma diagnosis and management.
Matasar MJ, Zelenetz AD. Matasar MJ, et al. Radiol Clin North Am. 2008 Mar;46(2):175-98, vii. doi: 10.1016/j.rcl.2008.03.005. Radiol Clin North Am. 2008. PMID: 18619375 Review.
Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma.
Dahi PB, Lee J, Devlin SM, Ruiz J, Maloy M, Rondon-Clavo C, Petrlik E, Tamari R, Shah G, Scordo M, Matasar MJ, Hamlin PA, Papadopoulos E, Jakubowski AA, Perales MA, Moskowitz CH, Sauter CS, Giralt SA. Dahi PB, et al. Among authors: matasar mj. Blood Adv. 2021 Jun 22;5(12):2608-2618. doi: 10.1182/bloodadvances.2020004167. Blood Adv. 2021. PMID: 34152404 Free PMC article.
Epidemiology of anaphylaxis in the United States.
Matasar MJ, Neugut AI. Matasar MJ, et al. Curr Allergy Asthma Rep. 2003 Jan;3(1):30-5. doi: 10.1007/s11882-003-0007-8. Curr Allergy Asthma Rep. 2003. PMID: 12542990 Review.
Imaging for Staging and Response Assessment in Lymphoma.
Johnson SA, Kumar A, Matasar MJ, Schöder H, Rademaker J. Johnson SA, et al. Among authors: matasar mj. Radiology. 2015 Aug;276(2):323-38. doi: 10.1148/radiol.2015142088. Radiology. 2015. PMID: 26203705 Review.
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP.
Bantilan KS, Smith AN, Maurer MJ, Teruya-Feldstein J, Matasar MJ, Moskowitz AJ, Straus DJ, Noy A, Palomba ML, Horwitz SM, Hamlin PA, Portlock CS, Cerhan JR, Habermann TM, Salles GA, Nowakowski GS, Moskowitz CH, Zelenetz AD. Bantilan KS, et al. Among authors: matasar mj. Blood Adv. 2024 May 14;8(9):2172-2181. doi: 10.1182/bloodadvances.2023011408. Blood Adv. 2024. PMID: 38271621 Free PMC article.
105 results